PIN28 A US Payer Cost-Effectiveness Analysis of Imipenem/Cilastatin/Relebactam Versus Colistin Plus Imipenem/Cilastatin in Patients with Carbapenem-Resistant Bacterial Infections
Abstract
Authors
J. Naik L. Ralph M. Massello R. Dillon E. Mccann J. Yang